Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McClellan FDA Commissioner Nomination Likely On Senate Fast Track

This article was originally published in The Gray Sheet

Executive Summary

The Senate Health, Education, Labor & Pensions Committee appears to be fast-tracking the confirmation process for FDA Commissioner-nominee Mark McClellan, MD/PhD
Advertisement

Related Content

FDA, CMS Coordination On Coverage Decisions May Improve Under McClellan
FDA, CMS Coordination On Coverage Decisions May Improve Under McClellan
FDA Commissioner McClellan? HHS’ Thompson Says Nomination Is Imminent
FDA Commissioner Pool: McClellan Fits Non-Industry Profile; Is That Enough?
Sen. Kennedy Warns Against Picking FDA Commissioner From Industry
Sen. Kennedy Warns Against Picking FDA Commissioner From Industry
Advertisement
UsernamePublicRestriction

Register

MT017224

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel